Thematics Asset Management Buys 85,000 Shares of Avantor, Inc. (NYSE:AVTR)

Thematics Asset Management boosted its position in Avantor, Inc. (NYSE:AVTR) by 9.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 950,000 shares of the company’s stock after purchasing an additional 85,000 shares during the quarter. Thematics Asset Management owned approximately 0.14% of Avantor worth $24,576,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Versant Capital Management Inc increased its position in shares of Avantor by 2,003.6% in the 2nd quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after acquiring an additional 1,102 shares during the period. Blue Trust Inc. lifted its holdings in shares of Avantor by 1,830.3% during the second quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after purchasing an additional 1,391 shares during the period. UMB Bank n.a. purchased a new stake in Avantor in the third quarter valued at approximately $49,000. Nisa Investment Advisors LLC raised its position in Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after buying an additional 835 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after buying an additional 1,285 shares during the last quarter. 95.08% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $25.06, for a total transaction of $88,336.50. Following the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. This represents a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is owned by insiders.

Analyst Ratings Changes

AVTR has been the topic of a number of research reports. Wells Fargo & Company cut their price objective on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. TD Cowen boosted their price objective on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday, July 29th. Morgan Stanley lifted their price target on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Barclays lowered their price objective on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Finally, Robert W. Baird decreased their target price on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Three analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Avantor has a consensus rating of “Moderate Buy” and a consensus target price of $27.57.

Avantor Trading Down 1.9 %

Shares of AVTR stock traded down $0.40 during trading on Tuesday, hitting $20.70. 714,127 shares of the stock traded hands, compared to its average volume of 6,486,139. Avantor, Inc. has a 52-week low of $19.59 and a 52-week high of $28.00. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. The firm has a market capitalization of $14.09 billion, a P/E ratio of 45.89, a price-to-earnings-growth ratio of 2.52 and a beta of 1.35. The firm’s fifty day moving average price is $23.77 and its 200-day moving average price is $23.82.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.